ALN-6400 clinical trials

A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

This study is looking into a new treatment called ALN-6400 for a genetic condition called Hereditary Hemorrhagic Telangiectasia (HHT). It's testing the treatment's safety and how well it works in both healthy volunteers and people living with HHT.